TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/23/07 14:29 | 5/22/07 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Browne G Morgan | NY | D | S.d | -377 | 37.66 | 0 | -10 | -27 | 27 | D | |||||||||||||||
8/21/06 16:54 | 8/17/06 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Browne G Morgan | NY | D | S.d | -183 | 36.50 | 0 | -5 | -16 | 27 | D | |||||||||||||||
6/3/04 17:29 | 6/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Browne G Morgan | NY | D | S.d | -813 | 81.27 | 0 | -10 | -30 | 24 | D | |||||||||||||||
3/5/04 11:19 | 3/3/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Browne G Morgan | NY | D | S.d | -600 | 40.00 | 0 | -15 | -40 | 23 | D | |||||||||||||||
1/6/04 09:26 | 1/2/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Browne G Morgan | NY | D | S | -165 | 32.95 | 0 | -5 | -15 | 28 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |